Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel Ga-68 PET bone-targeting agent tested in vivo, ex vivo and in metastatic bone cancer patients

June 20, 2014

AT-13148 well tolerated in ongoing first-in-human study

June 20, 2014

Biosimilar infliximab BOW-015 shows equivalence in phase III trial

June 20, 2014

First data presented for ZP-GG-72, a dual GLP-1/2 agonist

June 20, 2014

BMS-817399 fails to improve rheumatoid arthritis in phase II proof-of-concept study

June 19, 2014

Bioequivalence of LY-2963016 to originator insulin glargine

June 19, 2014

NNC-0151-0000 development halted, second-generation compound shows improved profile

June 19, 2014

ABP-501 proves equivalent to adalimumab in healthy volunteers

June 19, 2014

Results from phase I trial of PF-06438179, a biosimilar to infliximab

June 19, 2014

FDPA shows potential for imaging bacterial infections in the lung

June 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...